For the year ending 2025-12-31, CLRO had -$678K decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -26,084 |
| Amortization of right of use of assets | 256 |
| Share-based compensation expense | 79 |
| Non-cash interest expense | 28 |
| Loss on disposal of assets | -11,143 |
| Inventories | -39 |
| Accounts payable | -46 |
| Accrued liabilities | 289 |
| Operating lease liabilities | -258 |
| Net cash used in operating activities | -14,554 |
| Proceeds from maturities and sales of marketable securities | 0 |
| Purchases of marketable securities | 0 |
| Net cash provided by investing activities | 0 |
| Dividend payment | 0 |
| Proceeds from sale of stock | 1,000 |
| Proceeds from issuance of convertible note | 3,000 |
| Purchases of outstanding warrants | 33 |
| Proceeds from equity-based compensation programs | -1 |
| Net cash provided by (used) in financing activities | 3,966 |
| Net cash provided by operating activities | 7,032 |
| Net cash provided by investing activities | 2,912 |
| Net cash provided by financing activities | 0 |
| Net cash provided by discontinued operations | 9,944 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -34 |
| Net decrease in cash and cash equivalents and restricted cash | -678 |
| Cash and cash equivalents and restricted cash at the beginning of the year | 1,417 |
| Cash and cash equivalents and restricted cash at the end of the year | 739 |
CLEARONE INC (CLRO)
CLEARONE INC (CLRO)